A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration

Stopped early · Phase 1/Phase 2

Conditions studied: Age-Related Macular Degeneration

In brief

AG-013,958 is being studied to treat patients with Age-Related Macular Degeneration. A total of 144 subjects may be enrolled in the trial. Subjects will be male or female at least 55 years of age with "wet" age-related macular degeneration.

Key facts

Study ID

NCT00090532

Run by

Pfizer

People needed

155

Starts

2004-01-01

Expected to finish

2006-08-01

Last updated by the study team

2011-05-27

Who can join

Age: 55 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and/or female subjects >=55 years of age
• Subfoveal choroidal neovascularization complicating age-related macular degeneration
• Subjects who are informed of, and willing and able to comply with, the investigational nature of the study and are able to provide written informed consent in accordance with institutional and regulatory guidelines

You may not qualify if…

• Other serious ocular diseases or conditions, including diabetic retinopathy and glaucoma, that are likely to compromise visual acuity within 1 year

Where it is running

• Pfizer Investigational Site — Mesa, Arizona, United States
• Pfizer Investigational Site — Oro Valley, Arizona, United States
• Pfizer Investigational Site — Phoenix, Arizona, United States
• Pfizer Investigational Site — Sun City, Arizona, United States
• Pfizer Investigational Site — Tucson, Arizona, United States
• Pfizer Investigational Site — Tuscon, Arizona, United States
• Pfizer Investigational Site — Beverly Hills, California, United States
• Pfizer Investigational Site — Fort Myers, Florida, United States
• Pfizer Investigational Site — Tampa, Florida, United States
• Pfizer Investigational Site — Iowa City, Iowa, United States
• Pfizer Investigational Site — Chevy Chase, Maryland, United States
• Pfizer Investigational Site — Hagerstown, Maryland, United States
• Pfizer Investigational Site — Boston, Massachusetts, United States
• Pfizer Investigational Site — Ann Arbor, Michigan, United States
• Pfizer Investigational Site — Livonia, Michigan, United States
• Pfizer Investigational Site — Rochester, Michigan, United States
• Pfizer Investigational Site — Royal Oak, Michigan, United States
• Pfizer Investigational Site — Saint Clair Shores, Michigan, United States
• Pfizer Investigational Site — Ypsilanti, Michigan, United States
• Pfizer Investigational Site — Slingerlands, New York, United States
• Pfizer Investigational Site — Charlotte, North Carolina, United States
• Pfizer Investigational Site — Huntersville, North Carolina, United States
• Pfizer Investigational Site — Cleveland, Ohio, United States
• Pfizer Investigational Site — Lakewood, Ohio, United States
• Pfizer Investigational Site — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.